Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

Cited by (960)

Items 601–700 of 960

1. Enantiopure Cyclopropane-Bearing Pyridyldiazabicyclo[3.3.0]octanes as Selective ?4?2-nAChR Ligands
   Oluseye K. Onajole, Jason Brek Eaton, Ronald J. Lukas, Dani Brunner, Lucinda Thiede, Barbara J. Caldarone, Alan P. Kozikowski · 2014 · ACS Medicinal Chemistry Letters
2. The role of nicotinic receptors in alcohol consumption
   Helen M. Kamens, Geneva Flarend, William J. Horton · 2023 · Pharmacological Research
3. Identification of nicotine-seeking and avoiding larval zebrafish using a new three-choice behavioral assay
   H. Schneider, Anna Pearson, Drew Harris, Sabrina Krause, Andrew Tucker, Kaitlyn Gardner, Kuzivakwashe Chinyanya · 2023 · Frontiers in Molecular Neuroscience
4. Documento de consenso sobre tabaquismo y riesgo vascular
   José Abellán Alemán, Rafael Crespo Sabarís, Daniel Escribano Pardo, José Antonio García Donaire, Fernando García Romanos, Jesús Iturralde-Iriso, Luis Martín Penagos, L. Javier Nieto Iglesias, Alfonso Pobes Martínez de Salinas, Nicolás Roberto Robles et al. · 2024 · Hipertensión y Riesgo Vascular
5. Syntheses of the opioid substructures 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine and 2,3,4,5-tetrahydro-1,5-methano-1H-2-benzazepine
   Jotham W. Coe, Paige R. Brooks, Michael G. Vetelino, Crystal G. Bashore, Krista E. Bianco, Andrew C. Flick · 2010 · Tetrahedron Letters
6. Guideline Watch (April 2007): Practice Guideline for the Treatment of Patients With Substance Use Disorders, 2nd Edition
   Hilary Smith Connery, Herbert D. Kleber · 2007 · FOCUS The Journal of Lifelong Learning in Psychiatry
7. Smoking Cessation
   Juan Antonio Riesco Miranda, Carlos Andrés Jiménez Ruiz, José Carlos Serrano Rebollo · 2013 · Clinical Pulmonary Medicine
8. Varenicline promotes endothelial cell migration by lowering vascular endothelial-cadherin levels via the activated α7 nicotinic acetylcholine receptor–mitogen activated protein kinase axis
   Mitsuhisa Koga, Yuki Kanaoka, Keita Sugiyama, Kaoru Ohishi, Yuka Ejima, Mami Hisanaga, Yasufumi Kataoka, Atsushi Yamauchi · 2017 · Toxicology
9. Interventions for smoking cessation in patients admitted with Acute Coronary Syndrome: a review
   Omar Chehab, Habib Abbas Dakik · 2017 · Postgraduate Medical Journal
10. Efficacy of a sleep health intervention to optimize standard smoking cessation treatment response: results from a pilot randomized controlled trial
    Freda Patterson, Michael A. Grandner, Susan Kohl Malone, Ryan Todd Pohlig, Rebecca L. Ashare, David G. Edwards · 2020 · The Journal of Smoking Cessation
11. A Phase I, Double-blind, Randomized, Placebo-controlled, Single Dose-escalation Study to Evaluate the Tolerability, and Safety of Cytisinicline in Adult Smokers
    Cindy A. Jacobs, Marlene Fonseca, Nancy A. Rigotti, Neal L. Benowitz, Anthony Clarke, Dan Cain · 2022 · Nicotine & Tobacco Research
12. Pharmakologische Rückfallprävention bei Alkohol- und Tabakabhängigkeit
    Alexander Diehl, Karl F Mann · 2006 · Der Internist
13. Multiple Interaction Regions in the Orthosteric Ligand Binding Domain of the α7 Neuronal Nicotinic Acetylcholine Receptor
    Yun-De Xiao, Philip S. Hammond, Anatoly A. Mazurov, Daniel Yohannes · 2012 · Journal of Chemical Information and Modeling
14. Grover disease may result from the impairment of keratinocytic cholinergic receptors
    David A. Paslin · 2012 · Journal of the American Academy of Dermatology
15. Emerging drugs for the treatment of tobacco dependence
    Jon O. Ebbert · 2009 · Expert Opinion on Emerging Drugs
16. High-Throughput Patch Clamp Screening in Human α6-Containing Nicotinic Acetylcholine Receptors
    Lucas C. Armstrong, Glenn E. Kirsch, Nikolai B. Fedorov, Caiyun Wu, Yuri A. Kuryshev, Abby L. Sewell, Zhiqi Liu, Arianne L. Motter, Carmine S. Leggett, Michael S. Orr · 2017 · SLAS DISCOVERY
17. Review on Treatment of Substance Use Disorders
    Monicah Wanjiku Njoroge · 2017 · Journal of Addiction Research & Therapy
18. Exploring the interoceptive stimulus effects of nicotine and varenicline
    Brady M. Thompson, Scott T. Barrett, Rick A. Bevins · 2019 · Pharmacology Biochemistry and Behavior
19. Cue restricted smoking increases quit rates with varenicline
    Jaqueline Schölz Issa, Tania M O Abe, Patrícia Viviane Gaya, Bianca Boura Bellini, Iana R.A. de Moraes, Juliana M. B. Santos, Paulo Roberto Xavier Tomaz, Paulo de Lima Santos, Serena Tonstad · 2021 · Tobacco Prevention & Cessation
20. Role of Central Serotonin Receptors in Nicotine Addiction
    Massimo Pierucci, Stephanie Chambers, Lucy Partridge, Philippe De Deurwaerdère, Giuseppe Di Giovanni · 2014 · The Receptors
21. Green tobacco sickness: mecamylamine, varenicline, and nicotine vaccine as clinical research tools and potential therapeutics
    Lance Richard McMahon · 2019 · Expert Review of Clinical Pharmacology
22. Elucidating the reinforcing effects of nicotine: a tribute to Nadia Chaudhri
    Alan F. Sved, Anthony R. Caggiula, Eric C. Donny · 2022 · Psychopharmacology
23. Translational Approaches to Medication Development
    Selena E. Bartlett, Markus A Heilig · 2011 · Current topics in behavioral neurosciences
24. Adverse Neuropsychiatric Events Associated with Varenicline Use in Veterans: A Case Series
    Matthew A. Cantrell, Tami R. Argo, Lauren Haak, Laurel Janney · 2012 · Issues in Mental Health Nursing
25. Evaluating Treatment Mechanisms of Varenicline: Mediation by Affect and Craving
    Sarah Tonkin, Craig R. Colder, Martin Christopher Mahoney, Gary E. Swan, Paul M. Cinciripini, Robert A. Schnoll, Tony Peter George, Rachel Fynvola Tyndale, Larry W. Hawk · 2022 · Nicotine & Tobacco Research
26. Varenicline in Autistic Disorder: Hypothesis and Case Report of Single-Patient Crossover
    Lawrence Eugene Arnold, René Anand, Michael G. Aman · 2013 · Journal of Child and Adolescent Psychopharmacology
27. The potential of neuronal nicotinic acetylcholine receptor agonists for treating CNS conditions
    Michael W. Decker, Murali Gopalakrishnan, Michael D. Meyer · 2008 · Expert Opinion on Drug Discovery
28. The Influence of the Nitrogen Substitution in Three Cytisine Derivatives as Ligands for the Neuronal nAChRs: A Structural and Theoretical Study
    G. Bombieri, Fiorella Meneghetti, Roberto Artali, Bruno Tasso, Caterina Canu Boido, Fabio Sparatore · 2008 · Chemistry & Biodiversity
29. QM-polarized ligand docking accurately predicts the trend in binding affinity of a series of arylmethylene quinuclidine-like derivatives at the α4β2 and α3β4 nicotinic acetylcholine receptors (nAChRs)
    David C. Kombo, Vladimir P. Grinevich, Terry A. Hauser, Serguei S. Sidach, Merouane Bencherif · 2013 · Bioorganic & Medicinal Chemistry Letters
30. A manic episode in a 64-year-old man: an adverse effect of varenicline
    Amir I. A. Ahmed · 2011 · General Hospital Psychiatry
31. Success of a smoking cessation programme in smoking behaviour of chronic periodontitis patients and identification of predictors of motivation for smoking cessation – a pilot study
    Birgit Kropff, Gregor Petersilka, T Flemmig, Benjamin Ehmke, Gereon Heuft, Gudrun Schneider · 2015 · International Journal of Dental Hygiene
32. Species Differences in the Biotransformation of an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist: The Effects of Distinct Glucuronide Metabolites on Overall Compound Disposition
    Christopher L. Shaffer, Mithat Gunduz, Tim F. Ryder, Thomas N. O’Connell · 2009 · Drug Metabolism and Disposition
33. A Review of the Organic Synthesis and Medicinal Applications of the Natural Product Cytisine
    Dorota Bartusik‐Aebisher, David Aebisher, Piotr Tutka · 2016 · Modern Organic Chemistry Research
34. Nicotine- and cocaine-triggered methamphetamine reinstatement in female and male Sprague-Dawley rats
    Steven T. Pittenger, Shinnyi Chou, Scott T. Barrett, Isabella Catalano, Maxwell F. Lydiatt, Rick A. Bevins · 2017 · Pharmacology Biochemistry and Behavior
35. Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptors
    Marloes van Hout, Jessica L. Klein, Philip Kiær Ahring, David T. Brown, Siganya Thaneshwaran, Altair Brito dos Santos, Anders A. Jensen, Kristi A. Kohlmeier, Palle Christophersen, Tino Dyhring · 2019 · Biochemical Pharmacology
36. Is cytisine contraindicated in smoking patients with coronary artery disease after percutaneous coronary intervention?
    Bogumił Ramotowski, Andrzej Budaj · 2021 · Kardiologia Polska
37. Smoking cessation in Asians: focus on varenicline
    Dan Xiao, Shuilian Chu, Chen Wang · 2015 · Patient Preference and Adherence
38. The Effect of Varenicline Administration on Cannabis and Tobacco Use in Cannabis and Nicotine Dependent Individuals ? A Case-Series
    David A. L. Newcombe · 2015 · Journal of Addiction Research & Therapy
39. The risk of varenicline-induced seizure among those who have attempted to quit smoking using pharmacotherapy
    Divyan Chopra, Anuj Shah, Aisha Vadhariya, Jacob T. Painter · 2019 · Epilepsy & Behavior
40. Clinical utility of varenicline for smokers with medical and psychiatric comorbidity
    Jon O. Ebbert · 2009 · International Journal of COPD
41. Cost–effectiveness of varenicline for smoking cessation
    Hans Keiding · 2009 · Expert Review of Pharmacoeconomics & Outcomes Research
42. Comparing Smoking Cessation Interventions among Underserved Patients Referred for Lung Cancer Screening: A Pragmatic Trial Protocol
    Rachel A. Kohn, Anil Vachani, Dylan Small, Alisa J. Stephens Shields, Dorothy Sheu, Vanessa L. Madden, Brian A. Bayes, Marzana Chowdhury, Sadie Friday, Jannie Kim et al. · 2021 · Annals of the American Thoracic Society
43. Obstructive Sleep Apnea and Smoking Increase the Risk of Cardiovascular Disease: Smoking Cessation Pharmacotherapy
    Athanasia Pataka, Serafeim‐Chrysovalantis Kotoulas, Aliki Karkala, Asterios Tzinas, George Kalamaras, Nectaria Kasnaki, Evdokia Sourla, Emiliza Stefanidou · 2023 · Journal of Clinical Medicine
44. Molecular Pathogenesis, Organ Metastasis, and Targeted Therapy for Non-Small-Cell Lung Cancer
    Salik Abdullah, Ratul Chakraborty, Pratiksha Somnath Kumkar, Biplab Debnath, Asis Bala · 2024 · Journal of Environmental Pathology Toxicology and Oncology
45. Pharmacological properties and predicted binding mode of arylmethylene quinuclidine-like derivatives at the α3β4 nicotinic acetylcholine receptor (nAChR)
    David C. Kombo, Terry A. Hauser, Vladimir P. Grinevich, Matthew S. Melvin, Jon‐Paul Strachan, Serguei S. Sidach, Joseph Chewning, Nikolai B. Fedorov, Kartik Tallapragada, Scott R. Breining et al. · 2012 · Bioorganic & Medicinal Chemistry Letters
46. Insights Into the Differential Desensitization of α4β2 Nicotinic Acetylcholine Receptor Isoforms Obtained With Positive Allosteric Modulation of Mutant Receptors
    Roger L. Papke, Clare A. Stokes · 2022 · Molecular Pharmacology
47. Non-nicotine constituents in cigarette smoke extract enhance nicotine addiction through monoamine oxidase A inhibition
    Guanglin Liu, Ruiyan Wang, Huan Chen, Ping Wu, Yaning Fu, Kaixin Li, Mingda Liu, Zhihao Shi, Yuan Zhang, Yue Su et al. · 2022 · Frontiers in Neuroscience
48. Pyrazinecarboxylic Acid Derivatives with Antimycobacterial Activity
    Martin Doležal, Jan Zítko, Josef Jamplek · 2012 · InTech eBooks
49. Structure–Activity Studies of Diazabicyclo[3.3.0]octane-Substituted Pyrazines and Pyridines as Potent α4β2 Nicotinic Acetylcholine Receptor Ligands
    Marc J. C. Scanio, Lei Shi, William H. Bunnelle, David J. Anderson, Rosalind J. Helfrich, John Malysz, Kirsten Thorin‐Hagene, Ceclia E. Van Handel, Kennan C. Marsh, Chih‐Hung Lee et al. · 2011 · Journal of Medicinal Chemistry
50. Pyrazines and Their Benzo Derivatives
    Robert W. Huigens, Srinivasarao Tenneti, Tao Xiao, Aaron T. Garrison · 2021 · Elsevier eBooks
51. Safety and efficacy of early varenicline prescription in hospitalized patients with acute myocardial infarction: East Asian population
    Chien-Hsien Lo, Li-Ching Li, Kai-Wei Chang, Chin‐Feng Tsai, Chun-Hung Su, Tse-Hsien Lo, Chi‐Hua Yen, Kuei‐Chuan Chan · 2023 · Journal of the Formosan Medical Association
52. The Role of Halogen Bonding in Crystal Structures of 3-Halogeno Cytisine Derivatives
    Anna K. Przybył, Maciej Kubicki · 2012 · Journal of Chemical Crystallography
53. Partial nicotinic acetylcholine (α4β2) agonists as promising new medications for smoking cessation
    S Budhiraja, Jarnail Singh · 2008 · Indian Journal of Pharmacology
54. The effect of varenicline on Tp-e interval, Tp-e/QT ratio and Tp-e/QTc ratio in healthy smokers and nonsmokers
    Hasan Arı, Selma Arı, Selvi Coşar, Nuran Celiloğlu, İbrahim Aktaş, Sencer Çamcı, Kubra Doğanay, Ahmet Tütüncü, Mehmet Melek · 2015 · Cardiology Journal
55. Rapid nicotine tolerance and cross-tolerance to varenicline in rhesus monkeys: Drug discrimination.
    Megan Jo Moerke, Lance Richard McMahon · 2018 · Experimental and Clinical Psychopharmacology
56. Supporting cancer patients quit smoking: the initial evaluation of our tobacco cessation intervention program
    Ernest K Osei, Rahil Kassim, Kelly A. Cronin, Barbara-Anne Maier · 2019 · Journal of Radiotherapy in Practice
57. Interference with Smoking‐Cessation Effects of Varenicline After Administration of Immediate‐Release Amphetamine‐Dextroamphetamine
    Heather P. Whitley, Krystal L. Moorman · 2007 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
58. Drug Discoveries and Molecular Mechanism of Action
    David C. Swinney · 2015 · Wiley eBooks
59. Varenicline reduced smoking behaviour in a mentally ill person
    ELM Ochoa · 2008 · Journal of Psychopharmacology
60. Determinants of successful smoking cessation in outpatient settings: A comparative analysis of varenicline and free program interventions
    Yaohong He, J. Chen, Li-hua Zhao, Shuang Qu · 2025 · Tobacco Induced Diseases
61. Varenicline for the Treatment of Cocaine Dependence
    Kevin G. Lynch, Jennifer G. Plebani, Kelly Anne Spratt, Mark Morales, Mila A. Tamminga, Philip Feibush, Kyle Matthew Kampman · 2021 · Journal of Addiction Medicine
62. Functions and Pharmacology of Α2β2 Nicotinic Acetylcholine Receptors; in and Out of the Shadow of Α4β2 Nicotinic Acetylcholine Receptors
    Roger L. Papke · 2024 · Biochemical Pharmacology
63. Acetylcholine and Depression: Scrutinizing Future Therapeutic Targets for Novel Drug Development
    Arzoo Singh Pannu, Ramesh K. Goyal · 2024 · Current Clinical Pharmacology
64. Efficacy and safety of varenicline and bupropion, in combination and alone, for alcohol use disorder: a randomized, double-blind, placebo-controlled multicentre trial
    Bo Söderpalm, Helga Höifödt Lidö, Johan Franck, Anders Håkansson, Daniel Lindqvist, Markus A Heilig, Joar Guterstam, Markus Samuelson, Barbro Askerup, Cecilia Nilsson‐Wallmark et al. · 2025 · The Lancet Regional Health - Europe
65. The effect of switching pharmacological intervention during extinction on nicotine-evoked conditioned responding in rats
    Steven T. Pittenger, Lindsey C Zeplin, Linda P. Dwoskin, Rick A. Bevins · 2015 · Psychopharmacology
66. An appraisal of smoking cessation aids
    Kavita Mundey · 2009 · Current Opinion in Pulmonary Medicine
67. Electron impact mass spectral study of halogenated N ‐acetyl‐ and N ‐propionylcytisines
    Anna K. Przybył, Zdzisława Nowakowska · 2011 · Rapid Communications in Mass Spectrometry
68. Structure-based design, synthesis and structure–activity relationships of dibenzosuberyl- and benzoate-substituted tropines as ligands for acetylcholine-binding protein
    Ewald Edink, Atilla Akdemir, Chimed Jansen, René van Elk, Obbe P. Zuiderveld, Frans J. J. de Kanter, Jacqueline E. van Muijlwijk‐Koezen, August Benjamin Smit, Rob Leurs, Iwan J. P. de Esch · 2011 · Bioorganic & Medicinal Chemistry Letters
69. UFR2709, a Nicotinic Acetylcholine Receptor Antagonist, Decreases Ethanol Intake in Alcohol-Preferring Rats
    Gabriel Quiroz, Ramón Sotomayor‐Zárate, Juan Pablo González-Gutiérrez, Franco Viscarra, Felipe Moraga, Isabel Bermúdez, Miguel Iván Reyes-Parada, Marı́a Elena Quintanilla, Diego Lagos, Mario Rivera‐Meza et al. · 2019 · Frontiers in Pharmacology
70. The importance of acquisition learning on nicotine and varenicline drug substitution in a drug-discriminated goal-tracking task
    Brady M. Thompson, Scott T. Barrett, Y. Wendy Huynh, David A. Kwan, Jennifer E. Murray, Rick A. Bevins · 2020 · Pharmacology Biochemistry and Behavior
71. Core Modification of Cytisine: A Modular Synthesis
    Christoph Hirschhäuser, Claire A. Haseler, Timothy C. Gallagher · 2011 · Angewandte Chemie
72. Effects of Smoking and Need for Cessation: Biochemical and Pharmacological Feedback
    Manoranjan Adak · 2014 · Biochemistry & Pharmacology Open Access
73. NEUROSCIENTIFIC BASIS OF TREATMENT FOR SUBSTANCE USE DISORDERS
    Müge Bozkurt · 2022 · Nöro Psikiyatri Arşivi
74. Nicotinic Acetylcholine Receptors Along the Habenulo-Interpeduncular Pathway: Roles in Nicotine Withdrawal and Other Aversive Aspects
    Dang Q. Dao, Ramiro Salas, Mariella De Biasi · 2014 · The Receptors
75. Ion Channel Drug Discovery: a Historical Perspective
    Brian J. Cox · 2014 · Royal Society of Chemistry eBooks
76. The Effects of Nicotine on Learning and Memory
    Thomas J. Gould · 2014 · The Receptors
77. Varenicline in Autism: Theory and Case Report of Clinical and Biochemical Changes
    Mojdeh Mostafavi, Paul Hardy, Lawrence Eugene Arnold · 2016 · Journal of Child and Adolescent Psychopharmacology
78. Differential effects of α4β2 nicotinic receptor antagonists and partial-agonists on contextual fear extinction in male C57BL/6 mice
    Munir Gunes Kutlu, Jessica M. Tumolo, Courtney Cann, Thomas J. Gould · 2018 · Psychopharmacology
79. Varenicline: Smoking Cessation in Patients with Medical and Psychiatric Comorbidity
    Serena Tonstad, Charl Els · 2010 · Clinical Medicine Insights Therapeutics
80. Can Smoking for Positive or Negative Reinforcement Together With Dependence Help Us Better Diagnose Smokers?
    Karl Olov Fagerström, Carlos Andrés Jimenez-Ruiz, Jenaro Astray Mochales, Hans Gilljam · 2007 · The Journal of Smoking Cessation
81. Synthesis, Nicotinic Acetylcholine Binding, and in Vitro and in Vivo Pharmacological Properties of 2′-Fluoro-(carbamoylpyridinyl)deschloroepibatidine Analogues
    Pauline W. Ondachi, Ana H. Castro, Charles W. Luetje, Charles R. Wageman, Michael J. Marks, Mohamad Imad Damaj, S. Wayne Mascarella, Hernán A. Navarro, Frank Ivy Carroll · 2016 · ACS Chemical Neuroscience
82. Catalytic Synthesis and Application of Heterocyclic and Heteroatom Compounds
    Nayeem Ahmed, Zeba N. Siddiqui, Waqas A. Khan, Hinna Hamid · 2024 · Wiley eBooks
83. Transition Metal‐Catalyzed Transformations of Oxa/Aza Bicyclic Alkenes
    Fatemeh Doraghi, Shahab Kermaninia, Hadi Afaridoun, Bagher A. Larijani, Mohammad Mahdavi · 2024 · Asian Journal of Organic Chemistry
84. chrna3 Modulates Alcohol Response
    Joshua Raine, Caroline Kibat, Tirtha Das Banerjee, Antónia Monteiro, Ajay Sriram Mathuru · 2025 · Journal of Neuroscience
85. Varenicline mitigates the increased risk of pseudarthrosis associated with nicotine
    Brian A. Karamian, Hannah A. Levy, Goutham R. Yalla, Nicholas D. D’Antonio, Jeremy C. Heard, Mark James Lambrechts, José A. Canseco, Alexander Richard Vaccaro, Dessislava Markova, Christopher K. Kepler · 2023 · The Spine Journal
86. Evaluating mediators of the effect of varenicline preloading on smoking abstinence in a randomized controlled trial
    Samantha Johnstone, Robert K. Cooper, Jennifer M. Wray, Sarah Tonkin, Kyler S. Knapp, Craig R. Colder, Eugene Maguin, Martin Christopher Mahoney, Stephen T. Tiffany, Thomas Henry Brandon et al. · 2025 · Addiction
87. Molecular design, synthesis and physical properties of novel Cytisine-derivatives – Experimental and theoretical study
    Bojidarka B. Ivanova, Michael Spiteller · 2012 · Journal of Molecular Structure
88. Tratamiento farmacológico en la deshabituación tabáquica. Ventajas e inconvenientes de los tratamientos actuales
    José Antonio García-Galbis Marín, Mariano Leal Hernández, Fernando Hernández Menarguez, José Abellán Alemán · 2012 · Medicina de Familia SEMERGEN
89. Development and validation of the HPLC method for varenicline determination in pharmaceutical preparation
    Rafał Pietraś, Katarzyna Szymanska, Magda Kondej, Agata Gładysz, Dorota Kowalczuk · 2017 · Current Issues in Pharmacy and Medical Sciences
90. Nicotine Dependence among College Students Uninterested in Smoking Cessation during the COVID-19 Pandemic: A Cross-Sectional Survey
    Makoto Aoike, Yukihiro Mori, Yuka Aoyama, Mamoru Tanaka, Hana Kozai, Yukihiro Shigeno, Hatsumi Kawamura, Masato Tsurudome, Morihiro Ito · 2023 · International Journal of Environmental Research and Public Health
91. Reduction of nicotine and ethanol intake in alcohol-preferring (UChB) female rats by the α4β2 nicotinic acetylcholine receptor partial agonists 5-bromocytisine and cytisine
    Marı́a Elena Quintanilla, Mario Rivera‐Meza, Pablo Berríos‐Cárcamo, Bruce K. Cassels · 2023 · Drug and Alcohol Dependence
92. Efficacy of bupropion and varenicline genetic markers in choosing pharmacological treatment for smoking cessation, and implications for combining drugs: A randomized controlled trial (GENTSMOKING)
    Patrícia Viviane Gaya, Juliana Rocha Santos, Paulo Roberto Xavier Tomaz, Tânia Ogawa Abe, Miguel Nassif, Larissa G. Galas, Bianca Boura Bellini, Iana R.A. de Moraes, Paulo Caleb Júnior Lima Santos, Paulo César Rodrigues Pinto Corrêa et al. · 2024 · Tobacco Induced Diseases
93. Vareniclin – medikamentöse Therapie der Tabakabhängigkeit
    Patricia Tschabitscher, Irmgard Homaier, Alfred Lichtenschopf, Ernest Groman · 2009 · Wiener Medizinische Wochenschrift
94. Effects of varenicline on motor cortical plasticity in non-smokers with schizophrenia
    Alanna C. Bridgman, Mera S. Barr, Michelle S. Goodman, Reza Zomorrodi, Tarek K. Rajji, Bernard Le Foll, Robert E. Chen, Zafiris Jeff Daskalakis, Tony Peter George · 2016 · Schizophrenia Research
95. Short syntheses of 1-substituted dibenzothiophene derivatives
    Erin N. Welsh, Katherine N. Robertson, Alexander W. H. Speed · 2021 · Organic & Biomolecular Chemistry
96. A double blind randomized controlled trial investigating efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes: study protocol
    Cristina Russo, Pasquale Caponnetto, Fabio Cibella, Marilena Giovanna Maglia, Angela Alamo, Davide Campagna, Lucia Frittitta, M. Di Mauro, C. Leotta, Enrico G.M. Mondati et al. · 2021 · Internal and Emergency Medicine
97. The effect of varenicline on smoking and drinking outcomes among Black and White adults with alcohol use disorder and co-occurring cigarette smoking: A secondary analysis of two clinical trials
    Angela M. Haeny, Ralitza V. Gueorguieva, LaTrice Montgomery, Krysten W. Bold, Lisa M. Fucito, Ran Wu, Srinivas B. Muvvala, Allen Zweben, Stephanie S. O’Malley · 2021 · Addictive Behaviors
98. Substance Use: Disorders and Continuous Traits
    Levent Kirisci, Michael M. Vanyukov · 2022 · Springer eBooks
99. Varenicline Should Be Used as a First-Line Treatment to Help Smokers With Mental Illness Quit
    Jill M. Williams · 2012 · Journal of Dual Diagnosis
100. Varenicline: A Novel Nicotinic Receptor Partial Agonist for Smoking Cessation
     Jessica L. Kerr, Erin M. Timpe, Julie Phillips Karpinski · 2007 · Journal of Pharmacy Technology